Search
Pfizer Reportedly to Acquire Weight-Loss Drug Developer Metsera for $7.3 Billion
2025-09-22 /
Read about 0 minute
Author：小编
According to sources familiar with the matter, U.S. pharmaceutical giant Pfizer is on the verge of finalizing an acquisition deal worth a total of $7.3 billion for weight-loss drug developer Metsera. Under the terms of the agreement, Pfizer will acquire the company at a cash price of $47.50 per share, with an additional payment of $22.50 per share if Metsera achieves specific performance milestones. Unless negotiations fall through, the deal is expected to be officially announced as early as Monday.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
